Neerav Shukla

Author PubWeight™ 19.80‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapy. Nat Genet 2010 6.10
2 Mutational inactivation of STAG2 causes aneuploidy in human cancer. Science 2011 5.04
3 TFE3 fusions activate MET signaling by transcriptional up-regulation, defining another class of tumors as candidates for therapeutic MET inhibition. Cancer Res 2007 1.93
4 Coactivation of receptor tyrosine kinases in malignant mesothelioma as a rationale for combination targeted therapy. J Thorac Oncol 2011 1.02
5 Novel markers of subclinical disease for Ewing family tumors from gene expression profiling. Clin Cancer Res 2007 0.98
6 Allogeneic hematopoietic stem cell transplantation for pediatric patients with treatment-related myelodysplastic syndrome or acute myelogenous leukemia. Biol Blood Marrow Transplant 2011 0.82
7 Remission re-induction chemotherapy with clofarabine, topotecan, thiotepa, and vinorelbine for patients with relapsed or refractory leukemia. Pediatr Blood Cancer 2010 0.82
8 Insulin-like growth factor 1 receptor as a therapeutic target in ewing sarcoma: lack of consistent upregulation or recurrent mutation and a review of the clinical trial literature. Sarcoma 2013 0.80
9 Factors associated with relapse and survival in Wilms tumor: a multivariate analysis. J Pediatr Surg 2012 0.77
10 Osteosarcoma With Apparent Ewing Sarcoma Gene Rearrangement. J Pediatr Hematol Oncol 2016 0.75
11 High frequency of IDH-1 mutation links glioneuronal tumors with neuropil-like islands to diffuse astrocytomas. Acta Neuropathol 2011 0.75
12 High-dose cyclophosphamide for the treatment of refractory T-cell acute lymphoblastic leukemia in children. J Pediatr Hematol Oncol 2014 0.75
13 Erratum: Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients. Nat Med 2017 0.75
14 Effect of hemodialysis on the plasma levels of clofarabine. Pediatr Blood Cancer 2010 0.75
15 Intracardiac Low-grade Sarcoma Following Treatment for Ewing Sarcoma. J Pediatr Hematol Oncol 2017 0.75